rare youth project

Views & Analysis

The next generation of rare disease advocates need a little support in getting their voices heard as part of the Rare Youth Project.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.